Saladax Biomedical develops novel diagnostic assays for the practical delivery of personalized medicine and companion diagnostics. The company’s proprietary diagnostic tests improve the efficacy of cancer treatment by enabling oncologists to achieve optimal balance of efficacy and toxicity when administering chemotherapy agents. In addition, Saladax is a valuable partner for pharmaceutical and biotechnology companies in the development of companion diagnostics (CDx), addressing numerous risks and challenges in the new drug development process.



